Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Roberta Di Nicolantonio"'
Autor:
Jordi Esteve, Roberta Di Nicolantonio, Ainhoa Arenaza, Joaquin Martinez-Lopez, Aída Moure-Fernández, Jorge Sierra, Joana Gostkorzewicz, Joan Lluís Vinent, Raúl Diez, Pau Montesinos, Diana Martínez Llinàs, Carlos Martínez
Publikováno v:
ClinicoEconomics and Outcomes Research. 11:683-694
Purpose: The addition of midostaurin to standard chemotherapy (cytarabine and daunorubicin) has shown significant improvements in the survival of patients with acute myeloid leukemia with the FLT3 mutation (FLT3-AML). The objective of this study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::885e72b22a53762480cec83fd271530f
https://doi.org/10.2147/ceor.s222879
https://doi.org/10.2147/ceor.s222879
Autor:
Ainhoa, Arenaza, Raúl, Diez, Jordi, Esteve, Roberta, Di Nicolantonio, Joana, Gostkorzewicz, Carlos, Martínez, Diana, Martínez Llinàs, Joaquin, Martinez-Lopez, Pau, Montesinos, Aída, Moure-Fernández, Jorge, Sierra, Joan Lluís, Vinent
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Purpose The addition of midostaurin to standard chemotherapy (cytarabine and daunorubicin) has shown significant improvements in the survival of patients with acute myeloid leukemia with the FLT3 mutation (FLT3-AML). The objective of this study was t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eb972179d6385c4bbfc366750d082620
https://pubmed.ncbi.nlm.nih.gov/32009807
https://pubmed.ncbi.nlm.nih.gov/32009807